“prader-willi-syndrome” Archives

in
Entry Author Date Location
Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts 08/20/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Roundup: QL Demo Day, Millendo Therapeutics, Strata Oncology, More 03/27/19 Detroit Ann Arbor
FDA Halts Clinical Test of Zafgen Diabetes Drug, Stock Price Tumbles 11/26/18 Boston
Millendo Therapeutics Goes Public With OvaScience Reverse Merger 08/09/18 Detroit Ann Arbor
Zafgen Exec Thomas Hughes Resigns to Take CEO Job at Navitor 08/02/18 Boston
Future At Stake, Zafgen Gives First Glimpse of New Obesity Drug Data 05/04/17 Boston
ZappRx Gets $25M to Push E-Prescription Tools for Specialty Meds 04/20/17 Boston
Rhythm Raises $41M to Bankroll Late-Stage Push For Obesity Drug 02/16/17 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
After Zafgen Abandons Prader-Willi Drug, Could Rhythm Offer Hope? 07/28/16 Boston
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Zafgen Restructures, Abandons Obesity Drug Following FDA Meeting 07/19/16 Boston
East Coast Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech & More 05/12/16 Boston
East Coast Biotech Roundup: Alkermes, Zafgen, Snowmaggedon & More 01/22/16 Boston
Some Good News, Finally, for Zafgen’s Obesity Drug 01/20/16 Boston
Zafgen Shares Fall Again as Second Patient Dies in Trial 12/02/15 Boston
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
After a Clinical Trial Death, Zafgen Presses On, Families Stay Calm 11/23/15 Boston
East Coast Biotech Roundup: Cancer Vaccines, Biogen, LabCentral & More 10/23/15 Boston
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
FDA Puts a Hold on Zafgen’s Obesity Drug, Shares Slide 10/16/15 Boston
Breaking Silence, Zafgen Reveals Patient Died During Obesity Trial 10/14/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Levin Steps in as Ovid CEO, Confirms Plan to Target Rare Neuro Diseases 04/16/15 New York
ZappRx Nabs $5.6M, Inks Zafgen Deal to E-Prescribe Obesity Meds 04/02/15 Boston
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
Page 1 of 1